JPWO2020067453A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020067453A5
JPWO2020067453A5 JP2020549451A JP2020549451A JPWO2020067453A5 JP WO2020067453 A5 JPWO2020067453 A5 JP WO2020067453A5 JP 2020549451 A JP2020549451 A JP 2020549451A JP 2020549451 A JP2020549451 A JP 2020549451A JP WO2020067453 A5 JPWO2020067453 A5 JP WO2020067453A5
Authority
JP
Japan
Prior art keywords
weight
preparation according
lyophilized preparation
peptide
cyclodextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020549451A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020067453A1 (ja
JP7162675B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/038223 external-priority patent/WO2020067453A1/ja
Publication of JPWO2020067453A1 publication Critical patent/JPWO2020067453A1/ja
Publication of JPWO2020067453A5 publication Critical patent/JPWO2020067453A5/ja
Application granted granted Critical
Publication of JP7162675B2 publication Critical patent/JP7162675B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020549451A 2018-09-28 2019-09-27 注射用組成物 Active JP7162675B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018185532 2018-09-28
JP2018185532 2018-09-28
PCT/JP2019/038223 WO2020067453A1 (ja) 2018-09-28 2019-09-27 注射用組成物

Publications (3)

Publication Number Publication Date
JPWO2020067453A1 JPWO2020067453A1 (ja) 2021-09-09
JPWO2020067453A5 true JPWO2020067453A5 (https=) 2022-04-08
JP7162675B2 JP7162675B2 (ja) 2022-10-28

Family

ID=69951879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020549451A Active JP7162675B2 (ja) 2018-09-28 2019-09-27 注射用組成物

Country Status (10)

Country Link
US (1) US20210338587A1 (https=)
EP (1) EP3858377A4 (https=)
JP (1) JP7162675B2 (https=)
KR (1) KR20210068060A (https=)
CN (1) CN113382746A (https=)
AU (1) AU2019349329A1 (https=)
CA (1) CA3113212A1 (https=)
MX (1) MX2021003660A (https=)
NZ (1) NZ774063A (https=)
WO (1) WO2020067453A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024149926A (ja) * 2021-08-06 2024-10-23 ブライトパス・バイオ株式会社 がんペプチドワクチンカクテル製剤、及びその製造方法
EP4709424A1 (en) * 2023-05-08 2026-03-18 Integro Theranostics, LLC Lyophilized products, pharmaceutical compositions, and kits comprising dye-peptide conjugates and derivatives

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4932199A (en) 1998-07-31 2000-02-21 Haruo Sugiyama Cancer antigens based on tumor suppressor gene wt1 product
AR021849A1 (es) 1998-09-30 2002-08-07 Corixa Corp Composiciones y metodos para la inmunoterapia especifica de wt1
US20030072767A1 (en) 1998-09-30 2003-04-17 Alexander Gaiger Compositions and methods for WT1 specific immunotherapy
US20030235557A1 (en) 1998-09-30 2003-12-25 Corixa Corporation Compositions and methods for WT1 specific immunotherapy
WO2002047474A1 (en) 2000-12-13 2002-06-20 Sumitomo Pharmaceuticals Company, Limited Transgenic animal expressing hla-a24 and utilization thereof
EP1371664B1 (en) 2001-03-22 2008-01-09 International Institute of Cancer Immunology, Inc. Wti modified peptide
US7553494B2 (en) 2001-08-24 2009-06-30 Corixa Corporation WT1 fusion proteins
WO2003106682A1 (ja) 2002-06-12 2003-12-24 中外製薬株式会社 Hla−a24拘束性癌抗原ペプチド
ES2331305T3 (es) 2002-09-20 2009-12-29 International Institute Of Cancer Immunology, Inc. Peptidos de wt1 de tipo sustituido.
US7353321B2 (en) 2003-01-13 2008-04-01 Sierra Logic Integrated-circuit implementation of a storage-shelf router and a path controller card for combined use in high-availability mass-storage-device shelves that may be incorporated within disk arrays
KR101213015B1 (ko) 2003-11-05 2012-12-26 인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 Wt1 로부터 유도된 hla-dr 결합성 항원 펩티드
CA2548135C (en) 2003-12-01 2014-04-22 Sloan-Kettering Institute For Cancer Research Synthetic hla binding peptide analogues and uses thereof
EP1844789B8 (en) 2005-01-19 2014-10-08 Sumitomo Dainippon Pharma Co., Ltd. Emulsified composition for dilution and cancer vaccine composition
EP1951281B1 (en) 2005-10-17 2015-04-15 Sloan Kettering Institute For Cancer Research Wt1 hla class ii-binding peptides and compositions and methods comprising same
CA2631292C (en) 2005-11-30 2014-05-06 International Institute Of Cancer Immunology, Inc. Derivatised wt1 cancer antigen peptides and their use
WO2007120673A2 (en) 2006-04-10 2007-10-25 Sloan Kettering Institute For Cancer Research Immunogenic wt-1 peptides and methods of use thereof
WO2009046738A1 (en) * 2007-10-09 2009-04-16 Curevac Gmbh Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
EP2337795A2 (en) 2008-10-01 2011-06-29 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
AR076349A1 (es) 2009-04-23 2011-06-01 Int Inst Cancer Immunology Inc Peptido auxiliar del antigeno del cancer
SG11201507883SA (en) * 2013-03-29 2015-10-29 Sumitomo Dainippon Pharma Co Ltd Wt1-antigen peptide conjugate vaccine
ES2916834T3 (es) * 2014-09-27 2022-07-06 Sumitomo Pharma Co Ltd Composición farmacéutica para inyección
CN107921106B (zh) 2015-05-20 2023-09-08 住友制药株式会社 Wt1抗原肽和免疫调节剂的组合用途
US12383608B2 (en) 2016-11-30 2025-08-12 Sumitomo Pharma Co., Ltd. WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides

Similar Documents

Publication Publication Date Title
JP2016065060A5 (https=)
JP2020138981A5 (https=)
EP2635302B1 (fr) Procede pour ameliorer la production de virus et semences vaccinales influenza
JP2019504086A5 (https=)
JP2019131596A5 (https=)
JP2020518599A5 (https=)
JP2023113751A5 (https=)
JPWO2020067453A5 (https=)
JP2016505044A5 (https=)
JP2018528242A5 (https=)
JP2013531679A5 (https=)
JP2016130266A5 (https=)
JP2013513612A5 (https=)
JP2020015742A5 (https=)
CN108026515A (zh) 用于预防和/或治疗感染性疾病以及用于治疗肿瘤疾病的减毒流感病毒载体
US20240261398A1 (en) Adjuvant and vaccine containing adjuvant
JP2012516879A5 (https=)
JP2022552520A5 (https=)
EP2593135B1 (fr) Souches virales modifiées et procédé pour améliorer la production de semences vaccinales de virus influenza
JP2019516730A5 (https=)
JP2021502337A5 (https=)
JP2011524372A (ja) インフルエンザワクチン接種のための新規ペプチドアジュバント
US12606804B2 (en) Influenza virus backbone
BE1024228A1 (fr) Nouvelles formulations d'adjuvants
JP2014524450A5 (https=)